title: Molecular mimicry of trifluoroacetylated human liver protein adducts by constitutive proteins and immunochemical evidence for its impairment in halothane hepatitis.
abstract: A monospecific antibody (anti-CF3CO antibody) was obtained by affinity chromatography on a N epsilon-trifluoroacetyl-L-lysine (CF3CO-Lys) matrix of a rabbit polyclonal antiserum, directed against trifluoroacetylated protein adducts (CF3CO-proteins). The anti-CF3CO antibody recognized distinct CF3CO-proteins on immunoblots of a liver biopsy obtained from a human individual 10 h after halothane anaesthesia. Cross-reactive proteins of 52 kDa and 64 kDa were recognized on immunoblots of livers obtained from human individuals not exposed to halothane. Recognition of both CF3CO-proteins and the 52-kDa and 64-kDa cross-reactive proteins was abolished in the presence of 1 mM CF3CO-Lys. Anti-CF3CO antibody, affinity-adsorbed to the 52-kDa or the 64-kDa cross-reactive proteins of human liver, recognized the majority of target CF3CO-proteins on immunoblots of the human liver biopsy of an individual exposed to halothane. Liver biopsies of 5 out of 7 (71%) patients with halothane hepatitis exhibited an absence or low amounts of immunorecognizable 52-kDa and/or 64-kDa cross-reactive proteins. In contrast, of 22 control human individuals tested, all liver tissue samples were positive for the 52-kDa and/or the 64-kDa cross-reactive proteins. These data indicate that epitopes on the cross-reactive proteins of 52 kDa and 64 kDa of human liver bear strong immunochemical resemblance to epitopes on human liver CF3CO-proteins. Low-level expression of the cross-reactive proteins of 52 kDa and 64 kDa is discussed as one possible factor in human susceptibility to halothane hepatitis.
authors.affiliation: Department of Pharmacology, Biocenter of the University of Basel, Switzerland.
authors.forename: J
authors.initials: J
authors.lastname: Gut
authors.forename: U
authors.initials: U
authors.lastname: Christen
authors.forename: J
authors.initials: J
authors.lastname: Huwyler
authors.forename: M
authors.initials: M
authors.lastname: Bürgin
authors.forename: J G
authors.initials: JG
authors.lastname: Kenna
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury / Q000378:metabolism*; D002675:Child, Preschool; D005260:Female; D005463:Fluoroacetates; D006221:Halothane / Q000009:adverse effects*; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D008099:Liver / Q000737:chemistry* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight; D011506:Proteins / Q000032:analysis* / Q000737:chemistry / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D014269:Trifluoroacetic Acid / Q000378:metabolism
chemical_list: D005463:Fluoroacetates; D011506:Proteins; D014269:Trifluoroacetic Acid; D006221:Halothane